ArticleIranian journal of biotechnology2026
Identification and Analysis of PANoptosis Associated with Coronary Artery Disease Using Integrated Bioinformatics Methods.
Article in Iranian journal of biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coronary artery disease (CAD) is the leading cause of death in the world. Traditional imaging diagnostic techniques are difficult to be popularized due to the limitations of equipment and technical threshold. PANoptosis, as a synergistic integration form of apoptosis, necroptosis and pyroptosis, regulates multiple death pathways through PANoptosome complex, which is closely related to inflammation and organ damage. Objective: This study aims to integrate bioinformatics methods, comprehensively analyze the association between CAD and PANoptosis, and screen the key diagnostic markers. Materials and Methods: Three gene chip datasets (GSE12288, GSE20680 and GSE20681) were obtained from the GEO database, and 7 PANoptosis related differentially expressed genes (PRDEGs) were identified by Venn diagram overlap analysis to construct a CAD diagnostic model. The functional enrichment analysis of these PRDEGs was performed, and human umbilical vein endothelial cells (HUVEC) were used for in vitro functional verification. Results: FADD, PSTPIP2 and CASP8 were the core regulatory genes of CAD, and the logistic regression model based on three genes showed the best diagnostic efficiency (AUC=0.92). PRDEGs were mainly enriched in inflammatory factor signaling pathway, cell necrosis and pyroptosis pathway. Overexpression of FADD/CASP8 inhibited HUVEC proliferation and promoted apoptosis, while PSTPIP2 showed the opposite effect. Conclusion: This study reveals the molecular network of PANoptosis in CAD, and the constructed FADD-PSTPIP2-CASP8 diagnostic model provides a new tool for non-invasive screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.